Home LiteratureArticle Details
PMID: 8901614 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Zhang H, Dornadula G, Alur P, Laughlin MA, Pomerantz RJ

Abstract

Reverse transcription of HIV-1, without detergent or amphipathic peptide-induced permeability of the viral envelope, has been demonstrated to occur in the intact HIV-1 virion. In this report, we demonstrate that the amphipathic domains in the C terminus of the transmembrane glycoprotein (gp41) account for the natural permeability of the HIV-1 envelope to deoxyribonucleoside triphosphates, the substrates for DNA polymerization. In addition, nonphysiological deoxyribonucleoside triphosphates, such as 3'-azido-3'-deoxythymidine 5'-triphosphate and 3'-deoxythymidine 5'-triphosphate, can also penetrate the viral envelope, incorporate into, and irreversibly terminate reverse transcripts. As a result, viral infectivity is potently inhibited. Since the lentiviral envelope with these newly demonstrated characteristics can serve as a delivery pathway for anti-reverse transcription agents, we propose a unique strategy to prevent HIV-1 interand, possibly, intrahost transmission.

MeSH Terms
Animals Deoxyadenine Nucleotides/metabolism Deoxycytosine Nucleotides/metabolism Deoxyguanine Nucleotides/metabolism HIV Envelope Protein gp41/pharmacology HIV Reverse Transcriptase/metabolism HIV-1/pathogenicity Humans Mice Permeability/drug effects Rats Thymine Nucleotides/metabolism Transcription, Genetic/drug effects Virion/drug effects
Chemicals
Deoxyadenine Nucleotides Deoxycytosine Nucleotides Deoxyguanine Nucleotides HIV Envelope Protein gp41 Thymine Nucleotides 2'-deoxycytidine 5'-triphosphate deoxyguanosine triphosphate HIV Reverse Transcriptase 2'-deoxyadenosine triphosphate thymidine 5'-triphosphate
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Zhang H
Dorrance H. Hamilton Laboratories, Department of Medicine, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Dornadula G
Alur P
Laughlin M A
Pomerantz R J
References (41)
41 references, click to expand
  1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  2. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2',3'-dideoxynucleoside 5'-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thion e, and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.
    J Biol Chem. 1992 Jun 15;267(17):11769-76 PMID: 1376311
  3. Lipid composition and fluidity of the human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1988 Feb;85(3):900-4 PMID: 2829209
  4. Antimicrobial activity of synthetic magainin peptides and several analogues.
    Proc Natl Acad Sci U S A. 1988 Feb;85(3):910-3 PMID: 3277183
  5. Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes.
    J Cell Biol. 1988 Nov;107(5):1677-87 PMID: 3053734
  6. Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein.
    AIDS Res Hum Retroviruses. 1989 Feb;5(1):7-22 PMID: 2541749
  7. Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
    Gene. 1989 Apr 15;77(1):51-9 PMID: 2744487
  8. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity.
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):441-9 PMID: 2788444
  9. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity.
    J Virol. 1989 Oct;63(10):4395-403 PMID: 2778881
  10. Significance of premature stop codons in env of simian immunodeficiency virus.
    J Virol. 1989 Nov;63(11):4709-14 PMID: 2795718
  11. SIV adaptation to human cells.
    Nature. 1989 Oct 19;341(6243):573-4 PMID: 2677749
  12. Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 1990 Jan;87(2):648-52 PMID: 2300552
  13. Optimal conditions for synthesizing complementary DNA in the HIV-1 endogenous reverse transcriptase reaction.
    AIDS. 1990 Mar;4(3):199-206 PMID: 1693515
  14. The cytoplasmic tail of HIV-1 gp160 contains regions that associate with cellular membranes.
    Virology. 1991 Jan;180(1):439-41 PMID: 1984664
  15. Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range.
    J Virol. 1991 Jan;65(1):162-9 PMID: 1845882
  16. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs.
    J Biol Chem. 1991 Jan 25;266(3):1754-62 PMID: 1703154
  17. Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: characterization of the endogenous reverse transcriptase reaction.
    J Virol. 1991 Apr;65(4):1952-9 PMID: 1705993
  18. Localization of SIV in the genital tract of chronically infected female rhesus macaques.
    Am J Pathol. 1992 Sep;141(3):655-60 PMID: 1519670
  19. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.
    J Virol. 1992 Nov;66(11):6616-25 PMID: 1357190
  20. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers.
    Biochemistry. 1993 Mar 30;32(12):3112-8 PMID: 8457572
  21. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes.
    Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5181-5 PMID: 8389472
  22. Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.
    Virology. 1993 Sep;196(1):89-100 PMID: 8356808
  23. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
    Virology. 1993 Nov;197(1):255-64 PMID: 8212561
  24. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes.
    J Virol. 1994 Nov;68(11):7115-23 PMID: 7933093
  25. Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.
    J Virol. 1994 Nov;68(11):7591-7 PMID: 7933148
  26. Determinants of human immunodeficiency virus type 1 envelope glycoprotein oligomeric structure.
    J Virol. 1995 Feb;69(2):1209-18 PMID: 7815497
  27. Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies.
    J Virol. 1995 Jun;69(6):3929-32 PMID: 7538178
  28. Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein gp41.
    J Virol. 1995 Jul;69(7):4095-102 PMID: 7769667
  29. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9871-5 PMID: 7568235
  30. Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse transcriptase inhibitors in vivo.
    J Virol. 1996 Jan;70(1):628-34 PMID: 8523584
  31. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques.
    J Exp Med. 1996 Jan 1;183(1):215-25 PMID: 8551225
  32. Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.
    J Virol. 1996 May;70(5):2809-24 PMID: 8627755
  33. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
    Proc Natl Acad Sci U S A. 1986 Mar;83(6):1911-5 PMID: 3006077
  34. 1,4-Diaminobutane (putrescine), spermidine, and spermine.
    Annu Rev Biochem. 1976;45:285-306 PMID: 786151
  35. Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis.
    J Virol. 1981 Jan;37(1):117-26 PMID: 6260967
  36. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides.
    AIDS Res Hum Retroviruses. 1991 Jun;7(6):511-9 PMID: 1657072
  37. Intracellular metabolism of 3'-azidothymidine in isolated human peripheral blood mononuclear cells.
    AIDS Res Hum Retroviruses. 1991 Sep;7(9):751-9 PMID: 1742082
  38. Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein.
    J Biol Chem. 1992 Apr 5;267(10):7121-7 PMID: 1551918
  39. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
    J Virol. 1992 Jun;66(6):3306-15 PMID: 1583717
  40. Thymidine and 3'-azido-3'-deoxythymidine metabolism in human peripheral blood lymphocytes and monocyte-derived macrophages. A study of both anabolic and catabolic pathways.
    J Biol Chem. 1992 Jun 5;267(16):10968-75 PMID: 1597439
  41. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins.
    Virology. 1987 Jan;156(1):171-6 PMID: 3643678
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1996-10-29
Pages
12519-24
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC38024
Subset
IM
Grants
NIAID NIH HHS · AI33810 · United States
NIAID NIH HHS · AI36552 · United States
NIAID NIH HHS · AI38666 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com